香港股市 已收市

XORTX Therapeutics Inc. (XRTX)

NasdaqCM - NasdaqCM 延遲價格。貨幣為 USD。
加入追蹤清單
2.1000+0.0400 (+1.94%)
收市:04:00PM EDT
2.1900 +0.09 (+4.29%)
市前: 08:46AM EDT

XORTX Therapeutics Inc.

3710 – 33rd Street NW
Alberta Beach, AB T2L 2M1
Canada
(403) 455-7727
https://www.xortx.com

版塊Healthcare
行業Biotechnology
全職員工2

描述

XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury (AKI) associated with respiratory virus infection and associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. It has a collaboration and license agreements with the Icahn School of Medicine; and a license agreement with the University of Florida Research Foundation, Inc. The company is based in Alberta Beach, Canada.

公司管治

截至 無 止,XORTX Therapeutics Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。